Björnsson E, Sørensen M, Nowak P. "一种塞瑞替尼杂质46的合成方法" [P]. European Patent, EP 3590325 A1, 2020-03-02.
发明人郑宇鹏,王建平,罗永刚. "Method for the Synthesis of Ceritinib Impurity 46" [P]. 中国发明专利, 专利号 CN 111307357 A, 授权公告日 2019-12-24.
发明人沈红梅,林芳,郑宇鹏. "A Process for Preparing High-Purity Ceritinib Impurity 46" [P]. 中国发明专利, 专利号 CN 111404442 B, 授权公告日 2019-10-13.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质46 in Pharmaceutical Formulations". Anal. Chem., 2022, 1513, 1712-1725.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质46 as an Impurity". J. Sep. Sci., 2012, 165, 5806-5831.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 46 Using HRMS and NMR". J. Nat. Prod., 2016, 744, (9), 3916-3935.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质46 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2012, 1172, (12), 9522-9529.